Showing results (151-160 of 173) with videos related to

Sort By:
Pageof 18
Medrxiv : the Preprint Server for Health Sciences|November 14, 2023
Acute myeloid leukemia with mixed phenotype is characterized by RUNX1 mutations, stemness features and limited lineage plasticityPallavi Galera, Deepika Dilip, Andriy Derkach, et al.
The Lancet. Oncology|July 9, 2017
Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trialPaul D Brown, Karla V Ballman, Jane H Cerhan, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2017
Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group N0574 (Alliance) Randomized Controlled TrialThomas M Churilla, Karla V Ballman, Paul D Brown, et al.
International Journal of Radiation Oncology, Biology, Physics|October 27, 2019
Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3)Daniel M Trifiletti, Karla V Ballman, Paul D Brown, et al.
Cancer Discovery|February 15, 2017
Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2- and TET2-Mutant Acute Myeloid LeukemiaAlan H Shih, Cem Meydan, Kaitlyn Shank, et al.
Blood|January 15, 2025
Defining 2 biologically and clinically distinct groups in acute leukemia with a mixed phenotypePallavi Galera, Deepika Dilip, Andriy Derkach, et al.
JAMA Oncology|October 20, 2022
Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis: A Secondary Analysis of The N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) Randomized Clinical TrialJoshua D Palmer, Brett G Klamer, Karla V Ballman, et al.
Neuro-Oncology|April 6, 2024
Radical surgical resection with molecular margins is associated with improved survival in IDH wild-type glioblastomaElie Massaad, William J Smith, Joseph Bradley, et al.
Blood Advances|March 9, 2021
Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AMLMaximilian Stahl, Kamal Menghrajani, Andriy Derkach, et al.
JAMA|March 9, 2021
Effect of Ventral vs Dorsal Spinal Surgery on Patient-Reported Physical Functioning in Patients With Cervical Spondylotic Myelopathy: A Randomized Clinical TrialZoher Ghogawala, Norma Terrin, Melissa R Dunbar, et al.
Pageof 18